Treatment of Ph+ chronic myeloid leukemia by gamma interferon

Clicks: 161
ID: 261902
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #39 of 99 articles by views in blut

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The clinical, hematologic and cytogenetic effects of human recombinant gamma interferon (IFN) were investigated in 14 patients with Ph+ chronic myeloid leukemia (CML). Gamma-IFN was given at a daily dosage of 0.50 mg (=10×106 U)/m2 from the 3rd week of treatment on, but the dosage had to be reduced to 0.25 mg/m2 in 10 cases and to 0.35 mg/m2 in 2 cases, because of the severity and persistence of side effects (mainly fever, fatigue, headache and pain). Only 2 patients tolerated the full dosage. The overall response rate was 64% (1 complete and 8 partial hematologic responses). Only patients in stable chronic phase responded. Two out of two patients in unstable chronic phase and two out of two patients in accelerated phase failed to respond. Eight out of nine responding patients remained in remission throughout the duration of treatment (30 to 35 weeks). No karyotypic conversion was detected. These data show that gamma IFN alone is effective in Ph+ CML, but that side effects can limit substantially the dosage and duration of treatment.
Reference Key
russo1970bluttreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Domenico Russo;Renato Fanin;Eliana Zuffa;Cristiana Gallizia;Maria Grazia Michieli;Daniela Damiani;Nicoletta Testoni;Vanna Pecile;Giuseppe Visani;Roberto Colombini;Patrizia Tosi;Michele Baccarani;Sante Tura;Domenico Russo;Renato Fanin;Eliana Zuffa;Cristiana Gallizia;Maria Grazia Michieli;Daniela Damiani;Nicoletta Testoni;Vanna Pecile;Giuseppe Visani;Roberto Colombini;Patrizia Tosi;Michele Baccarani;Sante Tura;
Journal blut
Year 1970
DOI
doi:10.1007/BF00320241
URL
https://link.springer.com/article/10.1007/BF00320241
Keywords
oncology hematology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.